Although tumor location was not found to be an independent prognostic factor, patients with right-sided cancers had a higher proportion of poorly differentiated tumors, a higher percentage of postoperative serum CEA levels ≧ 5 ng/ml, more locally advanced tumors and more stage II and III diseases. The gene discussed is CEACAM5; the disease is cancer.